What this trial studies
Group A will receive tailored mat exercises. Group B will receive Mckenzie exercises. A baseline treatment including moist hot pack and TENS will be given to both of these groups. All these sessions will be of 45 minutes for 2 session per week for 10 weeks.
Conditions in scope
- Back Pain, Low
Interventions
- Tailored mat exercise program (Other) — The Group A will receive TENS plus moist hot pack and follow the Tailored mat exercise program for 10 weeks, two times per week, in 45-min sessions under supervision of trained physical therapist. The choice of exercises will be made…
- McKenzie exercises (Other) — The Group B will receive McKenzie exercises plus moist hot pack and TENS in the region of lumbar spine for 10 minutes and Mckenzie exercises of seven to ten repetitions for 45 min/session two times per week for ten weeks.…
Who can join
Women only · Ages 55 Years to 85 Years · Accepts healthy volunteers.
Inclusion criteria
- chronic nonspecific low back pain (more than 12 weeks)
- Moderate pain VAS\>30mm and\< 70mm
- TUG score of \< 15s
- Female who had entered menopause (menstrual periods have stopped for 12 months)
- Stable vital signs (patient is stable and vital signs are within normal limits)
- Multigravida
Exclusion criteria
- Frailer individuals
- Radiculopathy (signs of sensory loss, muscle weakness, reduced tendon reflexes)
- Women suffering from pathological conditions for example cardiac disease, cancer, vertebral fracture, osteomyelitis, Rheumatoid arthritis, cauda equina syndrome) participation in another lower back specific exercise program in the last 6 months
- Participation in a previous Pilates exercise program
- Neurodegenerative disease (e.g., Parkinson's disease)
- Recent stroke and cognitive impairment (Mini Mental State Exam score \< 24)
- History of recent fracture
Eligibility wording paraphrased from the public record. View the full criteria on ClinicalTrials.gov before contacting a site.
Where it’s happening
| City | State / Region | Facility | Site status |
|---|---|---|---|
| Lahore | Punjab Province | CMH (Combined Military Hospital) | Unknown |
Status & timeline
- Overall status: Completed
- Study type: Interventional
- Phase: N/A
- Start date: 2024-08-01
- Primary completion: 2025-07-01
- Last update posted: 2026-02-25
- First posted: 2024-12-27
Sponsor & contact
Lead sponsor: Riphah International University (Other)
For trial site contact information, use the official record at ClinicalTrials.gov. Contact details change frequently and the public record is the source of truth.
Outcome measures
Primary outcomes
- Visual analogue Scale (10th week)
Pain experienced in the last 24 h will be assessed with the pain VAS. The scale is an unnumbered 100 mm line, one end of which has the phrase "no pain" and the other "maximum pain". A mark is placed by the patient at a point representing their pain level. That mark is then measured by the tester with a… - Roland-Morris disability questionnaire (RMDQ) (10th week)
Roland-Morris disability questionnaire (RMDQ) The Greek version of the RMDQ was used to assess disability associated with low back pain in the last 24 h. This questionnaire has shown high test-retest reliability in older adults, with an intraclass correlation coefficient (ICC) of 0.85. The RMDQ consists of 24 items related to the daily activities patients often report having difficulty performing… - Timed up-and-go (TUG) test (10th week)
The TUG is a performance-based measure of functional mobility initially developed to identify mobility and balance impairments in older adults. The TUG has demonstrated high interrater and intrarater reliability when used to examine older adults (ICC=0. 99). The patient is scored based on the time required to perform the following sequence of actions: stand up from a chair, walk at…
Related ClearedRx care
If you’re reading this trial because you have menopause symptoms now, you don’t have to wait for a trial to access evidence-based care. ClearedRx prescribes the same FDA-approved and compounded HRT products that have been studied in trials like this one for decades.
Important. Information from ClinicalTrials.gov as of May 8, 2026. Trial details (status, sites, contacts, eligibility, outcomes) change frequently — always check the official record at https://clinicaltrials.gov/study/NCT06750380 before contacting a site.
ClearedRx is not affiliated with this trial or its sponsor. We index public-domain ClinicalTrials.gov records to help patients find evidence-based context for menopause care decisions. ClearedRx itself is a telehealth menopause/HRT brand — we do not enroll patients in trials.